Janssen GlobalVerified account

@JanssenGlobal

At Janssen, we never stop working toward a future where disease is a thing of the past. Channel run by Janssen Global Services LLC, NJ, USA.

Raritan, New Jersey
janssen.com
Joined May 2014
3,176 Photos and videos Photos and videos

Tweets

You blocked @JanssenGlobal

Are you sure you want to view these Tweets? Viewing Tweets won't unblock @JanssenGlobal

  1. Pinned Tweet
    Oct 21

    JUST IN: U.S. FDA authorizes our for emergency use for adults ages 18+ at least two months post-first shot. The Janssen COVID-19 Vaccine has not been approved/licensed by FDA.

    5 replies 6 retweets 19 likes
    Undo
  2. 15 minutes ago

    At we are reiterating our commitment to reduce the burden of stigma & improve health outcomes for people living with chronic hepatitis B. The NEW report from the spotlights critical steps needed to help end discrimination.

    Undo
  3. 19 hours ago

    We are excited to partner with to launch a toolkit dedicated to supporting caregivers throughout their care journeys, so they can be in a better position to care for their loved ones. Click to view the toolkit:

    2 retweets 4 likes
    Undo
  4. 22 hours ago

    Every day, Janssen Oncology remains focused on building a by helping address some of the toughest health challenges people face, including researching ways to eliminate cancer. Learn more about our work in action:

    1 retweet 2 likes
    Undo
  5. 23 hours ago

    We are proud to support in their efforts to recognize family caregivers and encourage them to celebrate the identities and passions that enrich their lives.

    1 reply 4 likes
    Undo
  6. 24 hours ago

    People living with chronic hepatitis B may hide their condition or not come forward for testing due to fear of rejection in the workplace. The NEW Stigma Report from the sheds light on discriminatory policies worldwide.

    3 likes
    Undo
  7. Nov 19

    The reality for patients worldwide: clinical trials aren’t just a nice-to-have, they’re a need-to-have. And clinical trials need people. If you live with an immunological condition and are seeking more equitable and inclusive research, learn more here:

    1 retweet 14 likes
    Undo
  8. Nov 18

    Today marks the start of World Antimicrobial Awareness Week (). Antimicrobial resistance is a global health crisis that, if left unaddressed, poses a substantial threat to humanity. At Janssen, we’re focused on efforts to infections through innovation.

    2 likes
    Undo
  9. Nov 18

    Thank you to all who joined us for . We discussed our plans for short- and long-term growth, therapeutic area innovations, and more.

    1 retweet 6 likes
    Undo
  10. Nov 18

    National Family Caregivers Month is an important time to recognize for their integral role in supporting loved ones with . We thank you today, and every day, for your commitment.

    Undo
  11. Nov 18

    This , have “More Talk” about risk factors for prostate cancer, such as a family history of the disease and race and/or ethnicity. Anyone at risk of developing prostate cancer should take “More Action” this , including getting screened.

    2 likes
    Undo
  12. Nov 18

    James List, Neil Davie, Bill Martin and David Lee discussing our therapeutic areas of focus with Vanessa Broadhurst and Scott White.

    5 likes
    Undo
  13. Nov 18

    Scott White discusses Janssen’s commitment to developing inventive medicines, therapies and vaccines to help address unmet need.

    1 like
    Undo
  14. Nov 18

    Vanessa Broadhurst, James List and Najat Khan examine Janssen’s pioneering of breakthrough approaches in retina disease at this year’s Pharmaceutical Business Review.

    13 likes
    Undo
  15. Retweeted
    Nov 18

    ., Vice Chairman of the Executive Committee, , discusses the future of healthcare at .

    1 reply 2 retweets 24 likes
    Undo
  16. Retweeted
    Nov 18

    Jennifer Taubert, EVP, Worldwide Chairman, Pharmaceuticals, , shares how ’s focus on transformational medicine is helping advance the next wave of innovation at .

    4 retweets 16 likes
    Undo
  17. Retweeted
    Nov 18

    Joe Wolk, Executive Vice President, Chief Financial Officer, , discusses the progress we've shared at .

    2 retweets 19 likes
    Undo
  18. Nov 18

    During a Q&A discussion, Vanessa Broadhurst outlined our plans to launch novel gene and cell therapies around the world.

    1 retweet 8 likes
    Undo
  19. Nov 18

    Vanessa Broadhurst and Scott White join Penny Heaton, Peter Lebowitz and James Merson in today’s therapeutic area Q&A panel. Moderated by Jen McIntyre.

    4 likes
    Undo
  20. Nov 18

    Teri Lawver speaks to the challenge of unlocking the full potential of an investigational medicine.

    1 retweet 4 likes
    Undo
  21. Nov 18

    Peter Lebowitz, Vanessa Broadhurst and Rich Tillyer at this year’s Pharmaceutical Business Review discussing advancements in lung cancer.

    14 likes
    Undo

@JanssenGlobal hasn't Tweeted yet.

Loading seems to be taking a while.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

    You may also like

    ·